Rahul Singhvi

Chief Executive Officer, Novavax.

Companies

Kairos Pharma, LTD.Board member Apr 30, 2025 to now¹
CodexisBoard member Sep 30, 2022 to now²
NovavaxBoard member Feb 22, 2006 to Mar 14, 2011³
NovavaxChief executive officer Feb 22, 2006 to Mar 14, 2011³
NovavaxPresident Feb 22, 2006 to Mar 14, 2011³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Codexis CDXS137,052 shares⁴$169.9K at $1.24Jun 10, 2025
Kairos Pharma, LTD. KAPA49,204 shares⁵$33.0K at $0.67Oct 8, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 8, 2025Granted 19,084 shares of Kairos Pharma, LTD.⁵
Jun 10, 2025Granted 40,983 shares of Codexis⁴
Jun 11, 2024Granted 30,120 shares of Codexis⁶
Jun 13, 2023Granted 34,602 shares of Codexis⁷
Sep 28, 2022Granted 31,347 shares of Codexis⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKairos Pharma, LTD., Board member
2
SEC EDGARCodexis, Board member
3
SEC EDGARNovavax, Board member
4
SEC EDGARCodexis shares after the filing of Jun 10, 2025
5
SEC EDGARKairos Pharma, LTD. shares after the filing of Oct 8, 2025
6
SEC EDGARForm 4 filed Jun 13, 2024
7
SEC EDGARForm 4 filed Jun 15, 2023
8
SEC EDGARForm 4 filed Sep 30, 2022